Physician profile
Allison Patel
NPI 1043906936
$1,485.57
in general payments reported to CMS, 2019-2025
19 companies · $74.40 in 2025
The $74.40 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $502 · 2024: $910 · 2025: $74.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,462 · Education: $24.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,461.51 |
| Education | $24.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $416.49 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $160.57 | 2023-2024 | Entyvio, Gattex |
| Regeneron Healthcare Solutions, INC. | $139.25 | 2023-2024 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.10 | 2023-2024 | Xifaxan, Trulance |
| Qol Medical, LLC | $113.54 | 2023-2024 | Sucraid, Sucraid |
| Janssen Biotech, INC. | $110.04 | 2023-2024 | Stelara |
| Genzyme Corporation | $99.91 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $63.25 | 2023-2024 | Dificid, Zinplava |
| Ironwood Pharmaceuticals, INC | $39.36 | 2023-2024 | Linzess |
| Neuraxis, INC. | $33.36 | 2025 | |
| Pfizer INC. | $30.01 | 2024 | |
| Fresenius Kabi USA, LLC | $24.40 | 2024 | Idacio |
| Celltrion USA INC. | $24.06 | 2024 | Zymfentra |
| Ardelyx, INC. | $21.67 | 2024 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $20.84 | 2023 | Ocaliva |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $19.71 | 2023 | Sutab |
| Aimmune Therapeutics, INC. | $17.37 | 2024 | |
| Celgene Corporation | $13.97 | 2023 | Zeposia |
| Nestle Healthcare Nutrition INC. | $13.67 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.